| 厄贝沙坦和贝那普利治疗轻中度原发性高血压的成本-效果分析 |
| 投稿时间：2005-08-26 点此下载全文 |
| 引用本文：吴雪,李传枚,乔化民.厄贝沙坦和贝那普利治疗轻中度原发性高血压的成本-效果分析[J].药学实践杂志,2006,(2):107~108 |
| 摘要点击次数: 1465 |
| 全文下载次数: 147 |
|
|
| 中文摘要:目的:评价应用厄贝沙坦和贝那普利治疗轻中度原发性高血压的成本-效果。方法:根据文献资料, 运用药物经济学的成本-效果分析方法,对厄贝沙坦和贝那普利治疗轻中度原发性高血压进行药物经济学评价。结果和结论:两组方案对于治疗轻中度原发性高血压的疗效比较无显著性差异,其治疗成本分别为 998.68元,923.08元,贝那普利的成本-效果比优于厄贝沙坦。 |
| 中文关键词:厄贝沙坦 贝那普利 成本-效果分析 原发性高血压 |
| |
| The cost-effectiveness analysis of irbesartan and benazepril in treating primary hypertension |
|
|
| Abstract:Objective: To evaluate cost-effectiveness of irbesartan and benazepril in the treatment of primary hypertension.Methods: According to literatures and method of cost-effectiveness analysis, two drugs with the treatment of primary hypertension were eco-nomicaly evaluated.Results and Conclusion: There were no obvious difference between these two projects in treating primary hypertension.The cost of treatment of two drugs were 998.68 and 923.08 yuan.The cost-effectiveness ratio of benazepril is superior to that of irbesartan. |
| keywords:irbesartan benazepril cost-effectiveness analysis primary hypertension |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
